MEDP
Medpace Holdings, Inc.
Price Chart
Latest Quote
$512.79
+39.31 (+8.30%)
Current Price
| Previous Close | $473.48 |
| Open | $479.00 |
| Day High | $517.83 |
| Day Low | $479.00 |
| Volume | 453,177 |
Stock Information
| Shares Outstanding | 28.56M |
| Total Debt | $146.09M |
| Cash Equivalents | $652.68M |
| Revenue | $2.68B |
| Net Income | $460.40M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $14.65B |
| P/E Ratio | 32.25 |
| EPS (TTM) | $15.90 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $14.14B |
| Sales | $2.68B |
| Income | $460.40M |
| Book/sh | $20.95 |
| Cash/sh | $22.85 |
| Employees | 6K |
Financial Ratios
| Quick Ratio | 0.78 |
| Current Ratio | 0.85 |
| Debt/Eq | 24.42 |
| EPS Growth TTM | 8.10% |
Returns & Margins
| ROA | 17.47% |
| ROE | 77.25% |
| Gross Margin | 71.90% |
| Operating Margin | 20.03% |
| Profit Margin | 17.19% |
Ownership
| Insider Ownership | 19.43% |
| Institutional Ownership | 88.63% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 27.33 |
| PEG | 2.80 |
| P/S | 5.47 |
| P/B | 24.48 |
Analyst Data
| Recommendation | hold |
| Target Price | $443.50 |
Technical Indicators
| SMA20 | $460.26 |
| SMA50 | $449.86 |
| SMA200 | $512.42 |
| RSI | 76.19 |
| ATR | 17.4786 |
| Shares Float | 22.99M |
| Short Float | 8.93% |
| Short Ratio | 6.05 |
| Volatility | 1.18 |
| Rel Volume | 1.55 |
Performance History
| Week | +11.09% |
| Month | +18.48% |
| Quarter | +11.30% |
| 6 Months | -9.78% |
| YTD | -10.20% |
| Year | +66.15% |
| 3 Years | +131.17% |
| 5 Years | +186.54% |
| 10 Years | +1745.23% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $512.79 | 453,177 |
| 2026-06-23 | $473.48 | 312,100 |
| 2026-06-22 | $455.66 | 385,400 |
| 2026-06-18 | $460.20 | 472,700 |
| 2026-06-17 | $457.09 | 240,100 |
| 2026-06-16 | $461.60 | 224,700 |
| 2026-06-15 | $467.50 | 265,900 |
| 2026-06-12 | $467.34 | 297,200 |
| 2026-06-11 | $475.07 | 249,700 |
| 2026-06-10 | $465.73 | 278,800 |
| 2026-06-09 | $466.79 | 284,300 |
| 2026-06-08 | $457.90 | 186,800 |
| 2026-06-05 | $454.25 | 190,600 |
| 2026-06-04 | $458.69 | 221,300 |
| 2026-06-03 | $450.82 | 240,100 |
| 2026-06-02 | $445.59 | 298,800 |
| 2026-06-01 | $451.47 | 251,200 |
| 2026-05-29 | $447.11 | 288,600 |
| 2026-05-28 | $448.12 | 484,000 |
| 2026-05-27 | $428.00 | 210,000 |
| 2026-05-26 | $429.11 | 293,500 |
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
đ° Latest News
3 Market-Beating Stocks to Target This Week
StockStory âĸ 2026-06-23T08:56:46Z
What Makes Medpace Holdings (MEDP) an Investment Bet?
Insider Monkey âĸ 2026-06-18T12:46:15Z
Medpace (MEDP) Suffers a Larger Drop Than the General Market: Key Insights
Zacks âĸ 2026-06-16T22:15:03Z
Medpace (MEDP) Stock Weighing Modest Undervaluation Against Rich P/E And Mixed Momentum
Simply Wall St. âĸ 2026-06-16T00:17:40Z
1 Profitable Stock to Consider Right Now and 2 We Brush Off
StockStory âĸ 2026-06-15T12:12:07Z
CON vs. MEDP: Which Stock Is the Better Value Option?
Zacks âĸ 2026-06-12T15:40:05Z
Madison Small Cap Fund Increased Medpace Holdings (MEDP), Downplaying AI Fears
Insider Monkey âĸ 2026-06-12T15:24:42Z
Why the Market Dipped But Medpace (MEDP) Gained Today
Zacks âĸ 2026-06-09T22:15:02Z
How Investors May Respond To Medpace (MEDP) Lawsuits And EVP Shift In Operating Leadership
Simply Wall St. âĸ 2026-06-06T01:05:52Z
3 Cash-Producing Stocks with Promising Prospects
StockStory âĸ 2026-06-04T20:37:30Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,769,616,000 | $1,452,749,000 | $1,361,337,000 | $1,027,558,000 |
| Cost Of Revenue | $1,769,616,000 | $1,452,749,000 | $1,361,337,000 | $1,027,558,000 |
| Total Revenue | $2,530,234,000 | $2,109,054,000 | $1,885,842,000 | $1,459,996,000 |
| Operating Revenue | $2,530,234,000 | $2,109,054,000 | $1,885,842,000 | $1,459,996,000 |
| Expenses | ||||
| Total Expenses | $1,995,299,000 | $1,662,184,000 | $1,549,017,000 | $1,181,299,000 |
| Other Income Expense | $-5,338,000 | $4,056,000 | $-655,000 | $7,068,000 |
| Other Non Operating Income Expenses | $2,393,000 | $4,552,000 | $1,274,000 | $3,209,000 |
| Net Non Operating Interest Income Expense | $12,780,000 | $24,996,000 | $-488,000 | $-2,905,000 |
| Total Other Finance Cost | $-12,780,000 | $-24,996,000 | $488,000 | $2,905,000 |
| Operating Expense | $225,683,000 | $209,435,000 | $187,680,000 | $153,741,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $451,123,000 | $404,386,000 | $282,810,000 | $245,368,000 |
| Net Interest Income | $12,780,000 | $24,996,000 | $-488,000 | $-2,905,000 |
| Normalized Income | $457,555,192 | $404,807,600 | $284,434,218 | $242,022,247 |
| Net Income From Continuing And Discontinued Operation | $451,123,000 | $404,386,000 | $282,810,000 | $245,368,000 |
| Total Operating Income As Reported | $534,935,000 | $446,870,000 | $336,825,000 | $278,697,000 |
| Net Income Common Stockholders | $451,123,000 | $404,342,000 | $282,619,000 | $245,211,000 |
| Net Income | $451,123,000 | $404,386,000 | $282,810,000 | $245,368,000 |
| Net Income Including Noncontrolling Interests | $451,123,000 | $404,386,000 | $282,810,000 | $245,368,000 |
| Net Income Continuous Operations | $451,123,000 | $404,386,000 | $282,810,000 | $245,368,000 |
| Pretax Income | $542,377,000 | $475,922,000 | $335,682,000 | $282,860,000 |
| Operating Income | $534,935,000 | $446,870,000 | $336,825,000 | $278,697,000 |
| Depreciation Amortization Depletion Income Statement | $28,124,000 | $29,251,000 | $26,328,000 | $22,341,000 |
| Depreciation And Amortization In Income Statement | $28,124,000 | $29,251,000 | $26,328,000 | $22,341,000 |
| Amortization Of Intangibles Income Statement | $946,000 | $1,443,000 | $2,199,000 | $3,352,000 |
| Depreciation Income Statement | $27,178,000 | $27,808,000 | $24,129,000 | $18,989,000 |
| Gross Profit | $760,618,000 | $656,305,000 | $524,505,000 | $432,438,000 |
| Per Share | ||||
| Diluted EPS | $15.28 | $12.63 | $8.88 | $7.28 |
| Basic EPS | $15.64 | $13.06 | $9.20 | $7.57 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,298,808 | $-74,400 | $-304,782 | $513,247 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $570,790,000 | $476,617,000 | $365,082,000 | $297,179,000 |
| Total Unusual Items | $-7,731,000 | $-496,000 | $-1,929,000 | $3,859,000 |
| Total Unusual Items Excluding Goodwill | $-7,731,000 | $-496,000 | $-1,929,000 | $3,859,000 |
| Reconciled Depreciation | $28,124,000 | $29,251,000 | $26,328,000 | $22,341,000 |
| EBITDA (Bullshit earnings) | $563,059,000 | $476,121,000 | $363,153,000 | $301,038,000 |
| EBIT | $534,935,000 | $446,870,000 | $336,825,000 | $278,697,000 |
| Diluted Average Shares | $29,527,000 | $32,014,000 | $31,841,000 | $33,671,000 |
| Basic Average Shares | $28,846,000 | $30,957,000 | $30,722,000 | $32,388,000 |
| Diluted NI Availto Com Stockholders | $451,123,000 | $404,342,000 | $282,619,000 | $245,211,000 |
| Otherunder Preferred Stock Dividend | $0 | $44,000 | $191,000 | $157,000 |
| Tax Provision | $91,254,000 | $71,536,000 | $52,872,000 | $37,492,000 |
| Gain On Sale Of Security | $-7,731,000 | $-496,000 | $-1,929,000 | $3,859,000 |
| Amortization | $946,000 | $1,443,000 | $2,199,000 | $3,352,000 |
| Selling General And Administration | $197,559,000 | $180,184,000 | $161,352,000 | $131,400,000 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-236,745,000 | $128,783,000 | $-139,255,000 | $-314,017,000 |
| Total Assets | $1,975,472,000 | $2,100,866,000 | $1,656,828,000 | $1,352,495,000 |
| Total Non Current Assets | $985,848,000 | $1,071,637,000 | $1,063,000,000 | $1,018,533,000 |
| Other Non Current Assets | $21,939,000 | $22,254,000 | $24,970,000 | $21,129,000 |
| Non Current Deferred Assets | $19,223,000 | $100,357,000 | $74,435,000 | $48,083,000 |
| Non Current Deferred Taxes Assets | $19,223,000 | $100,357,000 | $74,435,000 | $48,083,000 |
| Goodwill And Other Intangible Assets | $695,816,000 | $696,762,000 | $698,205,000 | $700,404,000 |
| Other Intangible Assets | $33,420,000 | $34,366,000 | $35,809,000 | $38,008,000 |
| Current Assets | $989,624,000 | $1,029,229,000 | $593,828,000 | $333,962,000 |
| Other Current Assets | $90,497,000 | $63,350,000 | $49,979,000 | $52,293,000 |
| Receivables | $402,078,000 | $296,443,000 | $298,400,000 | $253,404,000 |
| Receivables Adjustments Allowances | $-29,000 | $0 | $-7,000 | $-170,000 |
| Other Receivables | $25,352,000 | $5,347,000 | $22,475,000 | $40,405,000 |
| Accounts Receivable | $376,755,000 | $291,096,000 | $275,932,000 | $213,169,000 |
| Cash Cash Equivalents And Short Term Investments | $497,049,000 | $669,436,000 | $245,449,000 | $28,265,000 |
| Cash And Cash Equivalents | $497,049,000 | $669,436,000 | $245,449,000 | $28,265,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $113,643,000 | $126,234,000 | $142,122,000 | $188,867,000 |
| Long Term Debt And Capital Lease Obligation | $113,643,000 | $126,234,000 | $142,122,000 | $138,867,000 |
| Net Debt | - | - | - | $21,735,000 |
| Current Debt And Capital Lease Obligation | - | - | - | $50,000,000 |
| Current Debt | - | - | - | $50,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,516,401,000 | $1,275,321,000 | $1,097,878,000 | $966,108,000 |
| Total Non Current Liabilities Net Minority Interest | $172,653,000 | $170,768,000 | $172,747,000 | $162,638,000 |
| Other Non Current Liabilities | $57,655,000 | $42,734,000 | $28,221,000 | $22,701,000 |
| Non Current Deferred Liabilities | $1,355,000 | $1,800,000 | $2,404,000 | $1,070,000 |
| Non Current Deferred Taxes Liabilities | $1,355,000 | $1,800,000 | $2,404,000 | $1,070,000 |
| Current Liabilities | $1,343,748,000 | $1,104,553,000 | $925,131,000 | $803,470,000 |
| Other Current Liabilities | $52,834,000 | $53,633,000 | $40,441,000 | $47,547,000 |
| Current Deferred Liabilities | $854,390,000 | $710,585,000 | $559,860,000 | $462,729,000 |
| Payables And Accrued Expenses | $356,385,000 | $255,406,000 | $249,008,000 | $171,997,000 |
| Payables | $28,142,000 | $32,528,000 | $31,869,000 | $33,069,000 |
| Accounts Payable | $28,142,000 | $32,528,000 | $31,869,000 | $33,069,000 |
| Equity | ||||
| Common Stock Equity | $459,071,000 | $825,545,000 | $558,950,000 | $386,387,000 |
| Total Equity Gross Minority Interest | $459,071,000 | $825,545,000 | $558,950,000 | $386,387,000 |
| Stockholders Equity | $459,071,000 | $825,545,000 | $558,950,000 | $386,387,000 |
| Gains Losses Not Affecting Retained Earnings | $-4,906,000 | $-14,743,000 | $-10,072,000 | $-12,392,000 |
| Other Equity Adjustments | $-4,906,000 | $-14,743,000 | $-10,072,000 | $-12,392,000 |
| Retained Earnings | $-459,981,000 | $8,167,000 | $-221,645,000 | $-359,827,000 |
| Other | ||||
| Treasury Shares Number | $69,623 | $70,073 | $70,573 | $71,573 |
| Ordinary Shares Number | $28,370,780 | $30,630,799 | $30,752,292 | $31,091,694 |
| Share Issued | $28,440,403 | $30,700,872 | $30,822,865 | $31,163,267 |
| Tangible Book Value | $-236,745,000 | $128,783,000 | $-139,255,000 | $-314,017,000 |
| Invested Capital | $459,071,000 | $825,545,000 | $558,950,000 | $436,387,000 |
| Working Capital | $-354,124,000 | $-75,324,000 | $-331,303,000 | $-469,508,000 |
| Capital Lease Obligations | $113,643,000 | $126,234,000 | $142,122,000 | $138,867,000 |
| Total Capitalization | $459,071,000 | $825,545,000 | $558,950,000 | $386,387,000 |
| Treasury Stock | $12,156,000 | $12,235,000 | $12,322,000 | $12,497,000 |
| Additional Paid In Capital | $935,830,000 | $844,050,000 | $802,681,000 | $770,794,000 |
| Capital Stock | $284,000 | $306,000 | $308,000 | $309,000 |
| Common Stock | $284,000 | $306,000 | $308,000 | $309,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $113,643,000 | $126,234,000 | $142,122,000 | $138,867,000 |
| Current Deferred Revenue | $854,390,000 | $710,585,000 | $559,860,000 | $462,729,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $80,139,000 | $84,929,000 | $75,822,000 | $71,197,000 |
| Current Accrued Expenses | $328,243,000 | $222,878,000 | $217,139,000 | $138,928,000 |
| Goodwill | $662,396,000 | $662,396,000 | $662,396,000 | $662,396,000 |
| Net PPE | $248,870,000 | $252,264,000 | $265,390,000 | $248,917,000 |
| Accumulated Depreciation | $-123,272,000 | $-98,869,000 | $-79,404,000 | $-62,116,000 |
| Gross PPE | $372,142,000 | $351,133,000 | $344,794,000 | $311,033,000 |
| Construction In Progress | $12,773,000 | $21,167,000 | $7,182,000 | $10,518,000 |
| Other Properties | $171,167,000 | $174,292,000 | $184,728,000 | $170,919,000 |
| Machinery Furniture Equipment | $142,609,000 | $134,827,000 | $131,632,000 | $113,592,000 |
| Buildings And Improvements | $40,453,000 | $15,815,000 | $16,419,000 | $13,594,000 |
| Land And Improvements | $5,140,000 | $5,032,000 | $4,833,000 | $2,410,000 |
| Properties | $0 | $0 | $0 | $0 |
| Line Of Credit | - | - | $0 | $50,000,000 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $681,867,000 | $572,267,000 | $396,726,000 | $351,171,000 |
| Operating Activities | ||||
| Operating Cash Flow | $713,223,000 | $608,815,000 | $433,374,000 | $388,050,000 |
| Cash Flow From Continuing Operating Activities | $713,223,000 | $608,815,000 | $433,374,000 | $388,050,000 |
| Investing Activities | ||||
| Capital Expenditure | $-31,356,000 | $-36,548,000 | $-36,648,000 | $-36,879,000 |
| Investing Cash Flow | $-31,140,000 | $-28,308,000 | $-34,629,000 | $-38,742,000 |
| Cash Flow From Continuing Investing Activities | $-31,140,000 | $-28,308,000 | $-34,629,000 | $-38,742,000 |
| Net Other Investing Changes | $216,000 | $8,240,000 | $2,019,000 | $-1,863,000 |
| Capital Expenditure Reported | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-917,389,000 | $-169,867,000 | $-144,020,000 | $-847,849,000 |
| Financing Cash Flow | $-860,388,000 | $-154,009,000 | $-182,642,000 | $-775,775,000 |
| Cash Flow From Continuing Financing Activities | $-860,388,000 | $-154,009,000 | $-182,642,000 | $-775,775,000 |
| Net Common Stock Issuance | $-917,389,000 | $-169,867,000 | $-144,020,000 | $-847,849,000 |
| Other | ||||
| Repayment Of Debt | $0 | $0 | $-155,000,000 | $-274,200,000 |
| Issuance Of Debt | $0 | $0 | $105,000,000 | $324,200,000 |
| Interest Paid Supplemental Data | $0 | $171,000 | $3,056,000 | $2,935,000 |
| Income Tax Paid Supplemental Data | $39,719,000 | $83,567,000 | $76,353,000 | $50,164,000 |
| End Cash Position | $497,049,000 | $669,436,000 | $245,449,000 | $28,265,000 |
| Beginning Cash Position | $669,436,000 | $245,449,000 | $28,265,000 | $461,304,000 |
| Effect Of Exchange Rate Changes | $5,918,000 | $-2,511,000 | $1,081,000 | $-6,572,000 |
| Changes In Cash | $-178,305,000 | $426,498,000 | $216,103,000 | $-426,467,000 |
| Proceeds From Stock Option Exercised | $57,001,000 | $15,858,000 | $11,378,000 | $22,074,000 |
| Common Stock Payments | $-917,389,000 | $-169,867,000 | $-144,020,000 | $-847,849,000 |
| Net Issuance Payments Of Debt | $0 | $0 | $-50,000,000 | $50,000,000 |
| Net Short Term Debt Issuance | $0 | $0 | $-50,000,000 | $50,000,000 |
| Short Term Debt Payments | $0 | $0 | $-155,000,000 | $-274,200,000 |
| Short Term Debt Issuance | $0 | $0 | $105,000,000 | $324,200,000 |
| Net PPE Purchase And Sale | $-31,356,000 | $-36,548,000 | $-36,648,000 | $-36,879,000 |
| Purchase Of PPE | $-31,356,000 | $-36,548,000 | $-36,648,000 | $-36,879,000 |
| Change In Working Capital | $96,278,000 | $157,181,000 | $106,486,000 | $106,055,000 |
| Change In Other Working Capital | $155,042,000 | $174,519,000 | $87,524,000 | $140,142,000 |
| Change In Other Current Liabilities | $-25,160,000 | $-21,407,000 | $-18,873,000 | $-15,899,000 |
| Change In Payables And Accrued Expense | $99,712,000 | $13,917,000 | $83,131,000 | $58,907,000 |
| Change In Accrued Expense | $97,083,000 | $16,882,000 | $82,080,000 | $52,476,000 |
| Change In Payable | $2,629,000 | $-2,965,000 | $1,051,000 | $6,431,000 |
| Change In Account Payable | $2,629,000 | $-2,965,000 | $1,051,000 | $6,431,000 |
| Change In Prepaid Assets | $-27,101,000 | $-12,090,000 | $2,986,000 | $-10,175,000 |
| Change In Receivables | $-106,215,000 | $2,242,000 | $-48,282,000 | $-66,920,000 |
| Other Non Cash Items | $22,139,000 | $19,115,000 | $22,351,000 | $15,888,000 |
| Stock Based Compensation | $34,786,000 | $25,514,000 | $20,516,000 | $21,412,000 |
| Deferred Tax | $80,773,000 | $-26,632,000 | $-25,117,000 | $-23,014,000 |
| Deferred Income Tax | $80,773,000 | $-26,632,000 | $-25,117,000 | $-23,014,000 |
| Depreciation Amortization Depletion | $28,124,000 | $29,251,000 | $26,328,000 | $22,341,000 |
| Depreciation And Amortization | $28,124,000 | $29,251,000 | $26,328,000 | $22,341,000 |
| Amortization Cash Flow | $946,000 | $1,443,000 | $2,199,000 | $3,352,000 |
| Amortization Of Intangibles | $946,000 | $1,443,000 | $2,199,000 | $3,352,000 |
| Depreciation | $27,178,000 | $27,808,000 | $24,129,000 | $18,989,000 |
| Net Income From Continuing Operations | $451,123,000 | $404,386,000 | $282,810,000 | $245,368,000 |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Payments | - | - | - | - |
Fetched: 2026-06-22